Tumor-host interactions

Journal of Cellular Biochemistry

Volumn 93, Issue 5, 2004, Pages 871-877

  Tisdale, M J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Cancer cachexia; Lipid mobilizing factor; Lipolysis; Muscle atrophy; Proteasome proteolysis; Proteolysis inducing factor; Zinc 2 glycoprotein

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CYCLIC AMP; GLYCOPROTEIN; OLIGOSACCHARIDE; POLYPEPTIDE; UBIQUITIN; ZINC;

ARTICLE; BIOSYNTHESIS; CACHEXIA; CATABOLISM; GENE EXPRESSION; GLYCOSYLATION; HUMAN; MUSCLE MASS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; SKELETAL MUSCLE; TUMOR; ADIPOSE TISSUE; ANOREXIA; METABOLISM; MUSCLE ATROPHY; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANOREXIA; CACHEXIA; HUMANS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NEOPLASMS; WEIGHT LOSS;

EID: 17844367971     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20246     Document Type: Article

References (36)

1. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KCH. 1999. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81:80-86.
2. Beck SA, Tisdale MJ. 1989. Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Res 49:3800-3804.
3. Belizario JE, Katz M, Raw CI. 1991. Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss. Br J Cancer 63:705-710.
4. Bing C, Russell ST, Beckett EE, Collins P, Taylor S, Barraclough R, Tisdale MJ, Williams G. 2002. Expression of uncoupling proteins-1,-2, and-3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. Br J Cancer 86:612-618.
5. 2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA 101:2500-2505.
6. Bodine SC, Latres E, Baumhueter SI, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panora FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704-1708.
7. Bossola M, Muscaritoli M, Costelli P, Grieco G, Bonelli G, Pacelli F, Fanelli FR, Doglietto GB, Baccino FM. 2003. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Ann Surg 237: 384-389.
8. Cabal-Manzano R, Bhargava P, Torres-Duarte A, Marshall J, Bhargava P, Wanier IW. 2001. Proteolysis-inducing factor is expressed in tumors of patients with gastrointestinal cancers and correlates with weight loss. Br J Cancer 84:1599-1601.
9. De Wys WD. 1986. Weight loss and nutritional abnormalities in cancer patients: incidence, severity and significance. In: Calman KC, Fearon KCH, editors. Nutritional support for the cancer patient. London: W.B. Saunders. pp 251-261.
10. Evans WK, Makuch R, Clamon GH, Feld K, Weiner RS, Moran E, Blum R, Shepherd FA, Jeejeebhoy KW, De Wys WD. 1985. Limited impact of total parenteral nutrition on nutritional status during treatment for small cell lung cancer. Cancer Res 45:3347-3353.
11. Fearon KC, Preston T. 1990. Body composition in cancer cachexia. Infusionstherapie 17(Suppl 3):63-66.
12. Garcia-Martinez C, Lopez-Soriano FJ, Argiles JM. 1993. Acute treatment with tumour necrosis factor-α induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem 125:11-18.
13. Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. 1998. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 58:2359-2365.
14. Inagaki J, Rodriguez V, Bodey GP. 1974. Causes of death in cancer patients. Cancer 33:568-571.
15. Jagoe RT, Redfern CPF, Roberts RG, Gibson GJ. 2002. Skeletal muscle mRNA levels for cathepsin B but not components of the ubiquitin-proteasome pathway, are increased in patients with lung cancer referred for thoractomy. Clin Sci 102:353-361.
16. Lorite MJ, Cariuk P, Tisdale MJ. 1997. Induction of muscle protein degradation by a tumour factor. Br J cancer 76: 1035-1040.
17. Lorite MJ, Smith HJ, Arnold JA, Morris A, Thompson MG, Tisdale MJ. 2001. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 85:297-302.
18. Lowell BB, Ruderman NB, Goodman MN. 1986. Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem J 234:237-240.
19. Lundholm K, Bennegard K, Eden E, Svanringer G, Emery PW, Rennie MJ. 1982. Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss. Cancer Res 42:4807-4811.
20. Lundholm K, Daneryd P, Körner U, Hyltander A, Bosaeus I. 2004. Evidence that long-term COX treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 24:505-512.
21. McDevitt TM, Todorov PT, Beck SA, Khan SH, Tisdale MJ. 1995. Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumours in mice and humans. Cancer Res 55:1458-1463.
22. Palomares MR, Sayre JW, Shekar KC, Lillington LM, Chlebowski RT. 1996. Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients. Cancer 78:2119-2126.
23. Porter D, Weremowicz S, Chin K, Seth P, Keshaviah A, Lahti-Domenici J, Bae Y-K, Monitto CL, Merlos-Suarez A, Chan J, Hulette CM, Richardson A, Morton CC, Marks J, Duyao M, Hruban R, Gabrielson E, Gelman R, Polyak K. 2003. A neural survival factor is a candidate oncogene in breast cancer. Proc Natl Acad Sci USA 100:10931-10936.
24. Preston T, Slater C, McMillan DC, Falconer JS, Shenkin A, Fearon KC. 1998. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr 128:1355-1360.
25. Reeds PJ, Fjeld CR, Jahoon F. 1994. Do the differences between the amino acid composition of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states? J Nutr 124:906-910.
26. Rennie MJ, Edwards RHT, Emery PW, Halidey D, Lundholm K, Millward DJ. 1983. Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia. Clin Physiol 3:387-398.
27. Russell ST, Hirai K, Tisdale MJ. 2002. Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor. Br J Cancer 86:424-428.
28. Smith KL, Tisdale MJ. 1993. Mechanism of muscle protein degradation in cancer cachexia. Br J Cancer 68:314-318.
29. 12 myoblasts: Modulation by eicosapentaenoic acid. Cancer Res 59:5507-5513.
30. Thompson MP, Cooper ST, Parry BR, Tuckey JA. 1993. Increased expression of the mRNA for the hormone-sensitive lipase in adipose tissue of cancer patients. Biochem Biophys Acta 1180:236-240.
31. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. 1996. Characterization of a cancer cachectic factor. Nature 379:739-742.
32. Todorov PT, Deacon M, Tisdale MJ. 1997. Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation. J Biol Chem 272:12279-12288.
33. Todorov PT, McDevitt TM, Meyer DJ, Ueyama H, Ohkubo I, Tisdale MJ. 1998. Purification and characterization of a tumor lipid-mobilizing factor. Cancer Res 58:2353-2358.
34. Wang Z, Corey E, Hass GM, Higano CS, True LD, Wallace D, Jr., Tisdale MJ, Vessella RL. 2003. Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia. Int J Cancer 105:123-129.
35. Watchorn TM, Waddell ID, Dowidar N, Ross JA. 2001. Proteolysis-inducing factor regulates hepatic gene expression via the transcription factors NF-κB and STAT3. FASEB J 15:562-564.
36. Whitehouse AS, Tisdale MJ. 2003. Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-κB. Br J Cancer 89:1116-1122.